Principle
Hero Dependency is not a talent management problem. It is a valuation problem. When two individuals generate 65% of a company's net new ARR, the investor is not buying a commercial engine. They are buying a dependency on two people's continued goodwill, and paying a growth-company multiple for it.
Behaviour
The investment thesis for a growth-stage business rests on one assumption: that the revenue engine is repeatable and scalable. Hero Dependency breaks that assumption invisibly. The aggregate revenue curve is real, the growth rate is real, but the growth was produced by two people, not a system.
In a Hero Dependency organisation, the heroes are visibly different from the rest of the team in ways that feel cultural rather than operational. They are in more deals, involved in more escalations, mentioned first when the CRO is asked about performance. Management describes them in personality language: natural hunters, relationship builders, just wired differently.
What is not visible is the institutional dependency built up around them. Their accounts run on personal relationships that live in their phones, not the CRM. Their deals close through networks of internal champions nobody else can access. Their forecasting is accurate not through rigorous methodology but through accumulated intuition they cannot articulate and therefore cannot transfer. Below them, the rest of the team operates with less market access and no codified version of the playbook the heroes run instinctively. The rep at 65% of quota is not failing for lack of talent. They are failing without the network and institutional knowledge the heroes accumulated over years, which nobody has ever made available to them.
The heroes are not magic. They are methodical. The methodology exists. It lives in two people's heads. That is the difference between a commercial engine and a commercial dependency.
Evidence
The evidence is in the data, not the interviews. The heroes will not characterise themselves as a systemic risk, and management will not frame its best performers as a vulnerability.
The primary diagnostic is a Pareto analysis of individual ARR contribution over the last eight quarters. Plot every rep's net new ARR by quarter. In a Hero Dependency organisation the chart looks like a cliff: two or three bars that dwarf everything else, followed by a long tail of minimal contribution.
Cross-reference with tenure. The heroes have usually been with the organisation three or more years, long enough to build the network and tribal knowledge that makes their performance possible but not replicable. Then cross-reference with CRM data quality. The heroes' records are typically thinner than the rest of the team's, because they do not need the CRM to manage their deals. They carry the information in their heads and their relationships, which is further confirmation that the success is personal rather than institutional.
Psychology
Hero Dependency persists because of two cognitive mechanisms operating at once. The first is attribution error: the organisation credits the heroes' success to innate talent and personality rather than specific, replicable behaviours. If it is a gift, you cannot teach it, and if you cannot teach it, you do not need to try. The organisation absolves itself of systematising the success because it has decided the success is not systematic.
The second is survivorship bias applied to the growth narrative. Because the company is growing, the aggregate view suggests the system is working. The heroes are celebrated as evidence of a healthy culture rather than examined as a concentration risk. The growth rate makes the dependency invisible because it makes everything look fine.
Together these mechanisms make Hero Dependency self-concealing. The organisation does not see the risk because it has categorised the heroes' success as personal and cultural rather than operational and structural. The investor who accepts the organisation's own framing inherits the same blind spot.
Commercial Risk
Hero Dependency creates three distinct risks on different horizons. Departure risk is the most immediate: that one or both heroes leave post-acquisition. Ownership change, culture disruption, and incentive restructuring all raise the probability of a voluntary exit. A departure that was a 15% probability pre-acquisition can become 35 to 40% in the twelve months post-close. That probability, applied to the departing individual's ARR contribution, is the expected value of the risk, and it is almost never reflected in acquisition pricing.
Scaling ceiling risk: even if the heroes stay, every deal above a certain complexity gravitates to them, because they are the only people who can close it. Adding headcount does not resolve the bottleneck. Management incapacity risk: Hero Dependency and Co-Signing management are almost always found together, because the management tier never had to develop coaching capability while the heroes carried the organisation. When the heroes depart or become the bottleneck, that gap turns critical and expensive.
Investment Committee Note